Evidence map›Paper›PMID 32009222›Full record

ArticleJournal of assisted reproduction and genetics2020

Karyotype evaluation of repeated abortions in primary and secondary recurrent pregnancy loss.

T V Nikitina, E A Sazhenova, D I Zhigalina, E N Tolmacheva, N N Sukhanova, I N Lebedev

Open access · greenAbstract read
In one paragraph

Article in Journal of assisted reproduction and genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
7.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Genomics of pregnancy loss.Journal of assisted reproduction and genetics · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Squaring the circle of recurrent pregnancy loss (RPL).Journal of assisted reproduction and genetics · 2020
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

T V NikitinaResearch Institute of Medical Genetics, Laboratory of Cytogenetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Ushaika Street 10, Tomsk, 634050, Russia. t.nikitina@medgenetics.ru.ORCID https://orcid.org/0000-0002-4230-6855
E A SazhenovaResearch Institute of Medical Genetics, Laboratory of Cytogenetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Ushaika Street 10, Tomsk, 634050, Russia.ORCID https://orcid.org/0000-0003-3875-3932
D I ZhigalinaResearch Institute of Medical Genetics, Laboratory of Genomics of Orphan Diseases, Tomsk National Research Medical Center of the Russian Academy of Sciences, Ushaika Street 10, Tomsk, 634050, Russia.ORCID https://orcid.org/0000-0003-2800-8875
E N TolmachevaResearch Institute of Medical Genetics, Laboratory of Cytogenetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Ushaika Street 10, Tomsk, 634050, Russia.ORCID https://orcid.org/0000-0001-6427-3276
N N SukhanovaResearch Institute of Medical Genetics, Laboratory of Cytogenetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Ushaika Street 10, Tomsk, 634050, Russia.
I N LebedevResearch Institute of Medical Genetics, Laboratory of Cytogenetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Ushaika Street 10, Tomsk, 634050, Russia.ORCID https://orcid.org/0000-0002-0482-8046
Russian Academy of Sciences · RU

Funding

Ministry of Science and Education of the Russian Federation AAAA-A19-11902089005-5
6 · The paper itself

Abstract

purposeTo study the contribution of embryo chromosomal abnormalities in primary and secondary recurrent pregnancy loss (RPL) and to analyze the recurrence of chromosomal constitution in miscarriages from the same couple.

methodsRetrospective study of abortion karyotypes in RPL families based on the mother's primary or secondary RPL status (563 embryo specimens, 335 samples from primary, and 228 samples from secondary RPL). RPL was defined as two or more consecutive miscarriages. One hundred eight cases of recurrent embryo/fetal loss in 51 families were analyzed to assess the probability of having the same karyotype pattern (recurrent normal or recurrent abnormal) in both previous and subsequent pregnancy loss. The karyotypes of abortions were established using standard cytogenetic analysis, as well as interphase fluorescence in situ hybridization (FISH) and comparative genomic hybridization (CGH).

resultsThe frequency of aberrations was 43.9% in abortions from primary RPL versus 52.6% in secondary RPL (p = 0.041). Women 35 years of age or older were the main contributors to this difference. The odds ratio of a subsequent abortion having the same karyotype pattern (normal or abnormal) as the previous one was 6.98 (p = 0.0013).

conclusionThe frequency of abnormalities is higher in abortions from the secondary RPL versus primary RPL group, and this difference is due to the relative deficiency of miscarriages with abnormal karyotypes in older women with primary RPL. The probability of having the same karyotype pattern (recurrent normal or recurrent abnormal) in the previous and subsequent abortion is increased significantly compared with chance.

Indexed as

Chromosome AberrationsCytogenetic AnalysisKaryotypeAbortion, InducedAbortion, SpontaneousAdultAgedComparative Genomic HybridizationFemaleHumansIn Situ Hybridization, FluorescenceKaryotypingMaternal AgePregnancyChromosomal abnormalitiesCytogeneticsMiscarriagePrimary and secondary recurrent pregnancy loss

Identifiers

PMID32009222
PMCPMC7125272
OpenAlexW3003349843

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.